‘Dhurandhar: The Revenge’ Becomes Highest Grossing Indian Film Ever in U.S.

Dhurandhar: The Revenge grossed $22.7M in North America over 10 days, surpassing Baahubali 2's $22.0M (2017) to become the highest-grossing Indian film in the U.S./Canada. The film has crossed $143M worldwide after two weekends and is on pace to challenge RRR's $166M global total; it opened in 987 North American locations (vs Baahubali's 425), highlighting strong diaspora-driven demand but limited mainstream release.

Analysis

Diaspora-driven event films change the unit economics of theatrical windows: a tightly-targeted release in a handful of DMAs can deliver per-screen revenues that rival wide releases while using a fraction of the exhibitor footprint. For chains this creates a high-margin product to plug weekend revenue gaps — marginal benefit comes from repeat admissions and outsized concession capture rather than ticket count alone, so footprint quality (premium auditoria, F&B mix) matters more than scale.

Premium-format labeling (Filmed-for-Premium/IMAX-style) is a lever that multiplies that upside because it converts a niche title into an event with higher ticket yield and a marketing halo that is disproportionately efficient. The bottleneck is supply: limited premium auditoria and revenue-share economics mean upside accrues unevenly across participants — the format licensor and select multiplexes with premium seats win more than commodity screens.

Key reversals are predictable: compression of theatrical windows via early streaming rights sales, a sudden drop in repeat viewings once the core community is saturated, or geopolitical/content backlashes that throttle cross-border distribution. Watch distributor-exhibitor deal cadence and per-screen averages over the next few quarters for early signal changes; a sustained pipeline of tentpoles adopting premium-format releases would shift medium-term revenue allocation for exhibitors and licensors.

Second-order beneficiaries include regional marketers, F&B vendors, and cinema real-estate owners in high-density immigrant DMAs because they monetize the sticky footfall; lenders and REITs should reprice assets with concentrated ethnic-audience catchments. For investors the near-term playbook is event-driven exposure to premium-format capture and optional protection against broad-box commodity exhibitor outcomes.

Key Decisions for Investors

• Buy IMAX (IMAX) long-dated calls (12–18 month LEAPs) sized 1–2% of portfolio to play premium-format monetization; payoff skew is asymmetric — limited premium paid vs multi-bagger upside if a string of Indian tentpoles adopt the format and drive sustained per-screen yield. Exit or trim on 30–50% realized IV compression or if per-screen averages normalize.
• Pair trade: go long IMAX (equity or calls) and short a broad, commodity-focused exhibitor (example: initiate a small short/put on AMC) over a 6–12 month horizon — this isolates premium-format capture versus commodity weekend box office. Size the pair so net exposure is 0.5–1% portfolio and cap losses with a stop if both equities rally >25% on a general box-office boom.
• Event trigger trade: allocate a tactical tranche to buy IMAX equity or a call-spread following any announcement of distributor revenue-share deals or an announced rollout of additional premium auditoria in key overseas DMAs; such announcements historically re-rate the licensor quickly — target 2–3x return objective within 3–9 months, keep position small and time-limited.